scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0264-410X(99)00400-4 |
P698 | PubMed publication ID | 10618534 |
P2093 | author name string | C Walker | |
J E Wellington | |||
D N Love | |||
J M Whalley | |||
K M Ruitenberg | |||
P2860 | cites work | DNA-mediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model of EHV-1 respiratory infection | Q78164037 |
DNA vaccines | Q93896322 | ||
Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine | Q24650662 | ||
Comparison of the pathogenesis of acute equine herpesvirus 1 (EHV-1) infection in the horse and the mouse model: a review | Q33740622 | ||
Molecular evolution of herpesviruses: genomic and protein sequence comparisons | Q36630244 | ||
Expression of equine herpesvirus 1 glycoprotein D by using a recombinant baculovirus | Q40048086 | ||
Equine herpesviruses 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus). | Q40551622 | ||
The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse | Q40697575 | ||
A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation | Q40818252 | ||
Expression and characterization of equine herpesvirus 1 glycoprotein D in mammalian cell lines | Q41245831 | ||
N-terminal sequence analysis of equine herpesvirus 1 glycoproteins D and B and evidence for internal cleavage of the gene 71 product | Q41255203 | ||
Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model | Q41456995 | ||
DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors | Q41604739 | ||
Sequence analysis of a glycoprotein D gene homolog within the unique short segment of the EHV-1 genome | Q41704332 | ||
The role of CpG dinucleotides in DNA vaccines | Q41712102 | ||
The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection | Q41735689 | ||
Identification and comparative sequence analysis of a gene in equine herpesvirus 1 with homology to the herpes simplex virus glycoprotein D gene | Q42614342 | ||
Equine herpesvirus type 1 unique short fragment encodes glycoproteins with homology to herpes simplex virus type 1 gD, gI and gE. | Q42632643 | ||
Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene | Q45748454 | ||
Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice | Q47911816 | ||
Induction of neutralizing antibodies against HTLV-I envelope proteins after combined genetic and protein immunizations in mice. | Q52040861 | ||
Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep | Q64382425 | ||
Characterization of the glycoprotein D gene products of equine herpesvirus 1 using a prokaryotic cell expression vector | Q67488440 | ||
Potential of DNA-mediated vaccination for equine herpesvirus 1 | Q73028836 | ||
Nucleic acid vaccination of sheep: Use in combination with a conventional adjuvanted vaccine against Taenia ovis | Q73102471 | ||
Primary and challenge infection of mice with equine herpesvirus 1, strain HSV25A | Q77741414 | ||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1367-1373 | |
P577 | publication date | 2000-01-01 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naïve and infection-primed mice | |
P478 | volume | 18 |
Q40588197 | A protective effect of epidermal powder immunization in a mouse model of equine herpesvirus-1 infection |
Q40341555 | Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies. |
Q45436786 | Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines |
Q41962135 | Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model |
Q42982963 | Enhancement of humoral and cellular immunity in mice against Japanese encephalitis virus using a DNA prime-protein boost vaccine strategy |
Q74182723 | Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody |
Q43531044 | Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse |
Q43733752 | Equine herpesvirus 1 glycoprotein D expressed in Pichia pastoris is hyperglycosylated and elicits a protective immune response in the mouse model of EHV-1 disease |
Q74269517 | Immunization of BALB/c mice with DNA encoding equine herpesvirus 1 (EHV-1) glycoprotein D affords partial protection in a model of EHV-1-induced abortion |
Q45737947 | Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting |
Q36437406 | Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein |
Q44631879 | Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1. |
Q81384601 | Isolation and partial characterization of equine herpesvirus type 1 in Czechia |
Q38675720 | Prime-boost vaccine strategy against viral infections: Mechanisms and benefits. |
Q40547824 | Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins |
Q81589496 | Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals |
Q61804920 | Vaccine containing G protein fragment and recombinant baculovirus expressing M2 protein induces protective immunity to respiratory syncytial virus |
Q36601830 | Vaccines for viral and parasitic diseases produced with baculovirus vectors |
Search more.